![](/img/cover-not-exists.png)
Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis
Sakurai, Shintaro, Jojima, Teruo, Iijima, Toshie, Tomaru, Takuya, Usui, Isao, Aso, YoshimasaJournal:
Journal of Diabetes and its Complications
DOI:
10.1016/j.jdiacomp.2020.107703
Date:
July, 2020
File:
PDF, 1.62 MB
2020